LIFESTYLE DRUGS MARKET ANALYSIS

Lifestyle Drugs Market, by Drug Class (Phosphodiesterase (PDE) Inhibitors, 5-Alpha Reductase Inhibitors, Vasodilators, Prostamides, Neuromuscular Blocker, Stimulants, Contraceptives, and Antidepressants), by Application (Erectile Dysfunction, Baldness, Anti-ageing, Smart Drugs & Cognitive Enhancers, Energy Medication, Birth Control, Obesity, Smoking Cessation, and Others), by Dosage Form (Tablets, Oral Syrups, Gels, Creams, Parenteral and Chewing Gums), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Dec 2024
Code : CMI4489
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Global Lifestyle Drugs Market – Competitive landscape

Key players operating in the global lifestyle drugs market include Pfizer Inc, Biesterfeld Spezialchemie GmbH, Roman Inc, Sytheon Ltd., Unilever plc, Johnson & Johnson, Neutrogena Corporation, Oriflame cosmetics, Eli Lily &co, Novo Nordisk A/S, AstraZeneca plc. GlaxoSmithKline plc., and Allergan plc.